As of July 26, 2022, Pluri’s stock will trade under the symbol PLURThe new name reflects the Company’s strategy to leverage its innovative 3D cell-based.
Pluristem Therapeutics Inc. (NASDAQ:PSTI – Get Rating) was the target of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 584,400 shares, a decrease of 23.7% from the March 15th total of 765,900 shares. Based on an average daily volume of 1,420,000 shares, the […]
HAIFA, Israel, March 08, 2022 (GLOBE NEWSWIRE) Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading biotechnology company (“Pluristem”),.
Pluristem Therapeutics Inc. (NASDAQ:PSTI) went up by 21.77% from its latest closing price compared to the recent 1-year high of $9.89. The company’s stock price has collected 0.68% of gains in the last five trading sessions. Press Release reported 7 hours ago that Biotechnology Company Pluristem,